Programme

  1. Welcome and introduction

    by the conference moderator 

  2. Session 1: Office of Pesticide Programs (OPP) priorities and challenges

  3. EPA’s Antimicrobial Division’s 2022 accomplishments, and priorities for 2023

    • Office of Pesticide Programs (OPP) and the Antimicrobial Division (AD) organisation and staffing 
    • AD FY22 accomplishments 
    • AD FY23 priorities and challenges 
    • Salesforce implementation: PRIA/non-PRIA metrics 
    • Non-PRIA backlog proposal 
    • Registration review update 
  4. Industry response to the next phase of the EPA’s Registration Review Program

    • Current state of the EPA’s Registration Review Program— 
      • current timetable
      • types of response  
    • Industry response to the EPA’s interim decision (ID)/proposed interim decision (PID) actions— 
      • aside from shock…… 
      • initial approach  
    • Looming Registration Review concerns—
      • after responding to a PID what happens?
      • response timing
      • Endangered Species Act (ESA)/endocrine disruptor (ED) concerns 
  5. Emerging Federal Insecticide, Fungicide, and Rodenticide Act (FIFRA) legal and policy issues and the Congress: Implications for the pesticide community

  6. Q&A and panel discussion

  7. Refreshment break

  8. Session 2: Updates on Endangered Species Act (ESA) and other federal/state level developments

  9. Endangered species screen and implications of registration

  10. Navigating electronic Confidential Statement of Formula (eCSFs) for biocide registrations

    • History of eCSFs 
    • Overview of CDX process for creating/editing eCSFs 
    • Tips and tricks  
    • Challenges 
    • Summary 
  11. Introducing SmartLabel, a tool to enable ingredient transparency 

    • Four drivers of ingredient transparency 
    • Regulatory status of ingredient transparency 
    • SmartLabel demo 

     

  12. PFAS state by state regulation: Impact on pesticide packaging

    • Introduction 
    • State PFAS regulations and their impact on pesticides and pesticide packaging—
      • adopted
      • introduced
    • Compliance strategy
  13. Q&A

  14. Lunch

  15. Chemical Watch platform demonstration

  16. Session 3: Latest efficacy developments

  17. Interim guidance to support non-residential porous claims 

  18. Emerging viral pathogens guidance

  19. Surface coatings: changes to current testing methodologies and finalised testing guidelines

    • Changes in US residual testing guidance for coatings for public health use
      • residual self sanitisation (RSS)
      • residual self-disinfection (RSD)
      • supplemental residual coatings/fixed items 
    • Other residual methods for non-public health claims 
    • Residual testing methods under development 
  20. New testing protocols for air sanitisation

  21. Q&A

  22. Refreshment break

  23. Session 4: Canada – trends and updates

  24. Health Canada’s disinfectants update

    • Covid-19 pandemic response and lessons learned 
    • Emerging viral pathogens (EVP) list 
    • Proposed biocides regulations 
  25. Industry concerns with the Canadian PMRA’s transformation process

    • Status of the transformation process—
      • process changes 
      • continuous oversight/technology revisions
      • transparency  
    • Implementation schedule and perception—  
      • 2023 Implementation 
      • effect on re-evaluation process 
      • gaps 
  26. Q&A and final panel discussion

  27. End of conference